Average Co-Inventor Count = 11.67
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (11 from 822 patents)
2. Abbott Laboratories Corporation (6 from 4,177 patents)
3. Enanta Pharmaceuticals, Inc. (3 from 290 patents)
4. Reata Pharmaceuticals, Inc. (1 from 61 patents)
5. Enata Pharmacueticals, Inc. (1 from 1 patent)
6. Abbvie Bahamas Limited (6 patents)
7. Abbvie Ireland Unlimited Company (0 patent)
17 patents:
1. 10053474 - Anti-viral compounds
2. 9676797 - Anti-viral compounds
3. 9493506 - Macrocyclic hepatitis C serine protease inhibitors
4. 9464082 - Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
5. 9309279 - Macrocyclic hepatitis C serine protease inhibitors
6. 8951964 - Phenanthridine macrocyclic hepatitis C serine protease inhibitors
7. 8937041 - Macrocyclic hepatitis C serine protease inhibitors
8. 8748374 - Macrocyclic hepatitis C serine protease inhibitors
9. 8653141 - HIV protease inhibiting compounds
10. 8642538 - Macrocyclic hepatitis C serine protease inhibitors
11. 8497275 - HCV protease inhibitors and uses thereof
12. 8420596 - Macrocyclic hepatitis C serine protease inhibitors
13. 8193227 - HIV protease inhibiting compounds
14. 7902203 - Anti-infective agents
15. 7696226 - HIV protease inhibiting compounds